1. Hu, Shunfeng, Ren, Shuai, Cai, Yiqing, Zhou, Xiangxiang, Wang, Xin. 2021. Glycoprotein PTGDS promotes tumorigenesis of diffuse large B-cell lymphoma by MYH9-mediated regulation of Wnt-β-catenin-STAT3 signaling. In Cell death and differentiation, 29, 642-656. doi:10.1038/s41418-021-00880-2. https://pubmed.ncbi.nlm.nih.gov/34743203/
2. Rezaee, Shima, Kakavandi, Naser, Shabani, Mohammad, Hosseini-Fard, Seyed R, Najafi, Mohammad. . COX and PTGDS Gene Expression Levels in PGD2 Synthesis Pathway are Correlated with miR-520 in Patients with Vessel Restenosis. In Endocrine, metabolic & immune disorders drug targets, 20, 1514-1522. doi:10.2174/1871530320666200511012142. https://pubmed.ncbi.nlm.nih.gov/32389118/
3. Ren, Zhangping, Gao, Ming, Jiang, Wei. 2022. Prognostic role of NLGN2 and PTGDS in medulloblastoma based on gene expression omnibus. In American journal of translational research, 14, 3769-3782. doi:. https://pubmed.ncbi.nlm.nih.gov/35836891/
4. Semenova, Ekaterina I, Partevian, Suzanna A, Shulskaya, Marina V, Shadrina, Maria I, Alieva, Anelya Kh. 2023. Analysis of ADORA2A, MTA1, PTGDS, PTGS2, NSF, and HNMT Gene Expression Levels in Peripheral Blood of Patients with Early Stages of Parkinson's Disease. In BioMed research international, 2023, 9412776. doi:10.1155/2023/9412776. https://pubmed.ncbi.nlm.nih.gov/38027039/
5. Chen, Mengting, Yang, Li, Zhou, Peijie, Deng, Zhili, Li, Ji. 2024. Single-cell transcriptomics reveals aberrant skin-resident cell populations and identifies fibroblasts as a determinant in rosacea. In Nature communications, 15, 8737. doi:10.1038/s41467-024-52946-7. https://pubmed.ncbi.nlm.nih.gov/39384741/
6. Wu, Wantao, Li, He, Wang, Zeyu, Li, Shuyu, Zhang, Chi. 2023. The tertiary lymphoid structure-related signature identified PTGDS in regulating PD-L1 and promoting the proliferation and migration of glioblastoma. In Heliyon, 10, e23915. doi:10.1016/j.heliyon.2023.e23915. https://pubmed.ncbi.nlm.nih.gov/38205335/
7. Chen, Bohong, Guo, Li, Wang, Lihui, Wu, Dapeng, Du, Yuefeng. 2024. Leveraging cell death patterns to predict metastasis in prostate adenocarcinoma and targeting PTGDS for tumor suppression. In Scientific reports, 14, 21680. doi:10.1038/s41598-024-72985-w. https://pubmed.ncbi.nlm.nih.gov/39289451/
8. Zou, Ruoyao, Zheng, Mingjun, Tan, Mingzi, Luan, Nannan, Zhu, Liancheng. 2020. Decreased PTGDS Expression Predicting Poor Survival of Endometrial Cancer by Integrating Weighted Gene Co-Expression Network Analysis and Immunohistochemical Validation. In Cancer management and research, 12, 5057-5075. doi:10.2147/CMAR.S255753. https://pubmed.ncbi.nlm.nih.gov/32617019/
9. Geng, Lu, Gao, Wenqing, Saiyin, Hexige, Zhang, Zhuohua, Li, Jixi. 2023. MLKL deficiency alleviates neuroinflammation and motor deficits in the α-synuclein transgenic mouse model of Parkinson's disease. In Molecular neurodegeneration, 18, 94. doi:10.1186/s13024-023-00686-5. https://pubmed.ncbi.nlm.nih.gov/38041169/
10. Choi, Dong-Joo, An, Jiawei, Jou, Ilo, Park, Sang Myun, Joe, Eun-Hye. 2019. A Parkinson's disease gene, DJ-1, regulates anti-inflammatory roles of astrocytes through prostaglandin D2 synthase expression. In Neurobiology of disease, 127, 482-491. doi:10.1016/j.nbd.2019.04.003. https://pubmed.ncbi.nlm.nih.gov/30954702/